Conference - London, United Kingdom
Returning for its 4th year and following on from the major success of previous events, SMi is proud to announce that registration is now live for the Orphan Drugs and Rare Diseases Conference taking place on 19th – 20th October 2015 in London, UK.
Through a series of interactive presentations and panel discussions, attendees will learn how payers, pharmaceutical, biotech, patient organisations and academia are structuring to participate in and leverage the growing orphan drugs and rare diseases market.
Key topics include:
• The development of ultra-orphan drugs to prevent, diagnose and treat rare diseases
• Strategies for overcoming the challenges for reimbursement of orphan and ultra-orphan drugs
• How to create workable partnerships for future development of drugs
• The development of ultra-orphan drugs to prevent, diagnose and treat rare diseases
• Strategies for overcoming the challenges for reimbursement of orphan and ultra-orphan drugs
• How to create workable partnerships for future development of drugs
Confirmed organisations include: GW Pharmaceuticals, PSR Orphan Experts, PSR Group B.V., Shire Pharmaceuticals Limited, Cello Health Insight – London, Infusion Pharma Consulting LLC, Otsuka Europe Development and Commercialisation
- Organization: SMi Group
- Orphan Drugs and Rare Diseases
Mon, Oct 19, 2015 - Tue, Oct 20, 2015
Holiday Inn Regents Park
London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
